Abrupt emergence of diverse species B adenoviruses at US military recruit training centers

被引:127
作者
Metzgar, David
Osuna, Miguel
Kajon, Adriana E.
Hawksworth, Anthony W.
Irvine, Marina
Russell, Kevin L.
机构
[1] Naval Hlth Res Ctr, Resp Dis Lab, Dept Def Ctr Deployment Hlth Res, San Diego, CA 92186 USA
[2] Lovelace Resp Res Inst, Program Infect Dis, Albuquerque, NM USA
关键词
D O I
10.1086/522970
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Adenoviruses (Ads) cause continuous outbreaks of acute respiratory disease (ARD) in US military training facilities. In 1996, the loss of vaccines targeting the dominant recruit- associated serotypes precipitated the reemergence of Ads in these populations. Between 1999 and 2002, serotype 4 accounted for >95% of Ads isolated from recruits and for >50% of ARD cases in training facilities (15,000 cases/year). Methods. Ads (n = 1867) collected between 2002 and 2006 from recruits with ARD at 8 military training facilities in the United States were serotyped by serum neutralization and polymerase chain reaction. Results. The dominance of Ad4 continued through 2005, followed by a simultaneous emergence of diverse species B serotypes at the majority of sites. This included the subspecies B1 serotypes 3, 7, and 21 and the subspecies B2 serotype 14. Ad14 was the most prevalent species B serotype, appearing in high numbers at 3 sites and becoming dominant at 1. Conclusions. Subspecies B2 Ads have rarely been associated with ARD, and only in Eurasia. This survey represents the first report of AdB2- associated ARD in the Western Hemisphere. The simultaneous emergence of several species B Ads suggests a common external source (the civilian population) and a decrease in preexisting immunity to species B Ads.
引用
收藏
页码:1465 / 1473
页数:9
相关论文
共 41 条
[31]   WORLDWIDE EPIDEMIOLOGY OF HUMAN ADENOVIRUS INFECTIONS [J].
SCHMITZ, H ;
WIGAND, R ;
HEINRICH, W .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1983, 117 (04) :455-466
[32]   SIMULTANEOUS ADMINISTRATION OF LIVE, ENTERIC-COATED ADENOVIRUS TYPES-4, TYPES-7, AND TYPES-21 VACCINES - SAFETY AND IMMUNOGENICITY [J].
TAKAFUJI, ET ;
GAYDOS, JC ;
ALLEN, RG ;
TOP, FH .
JOURNAL OF INFECTIOUS DISEASES, 1979, 140 (01) :48-53
[33]  
van der VEEN J., 1963, AMER REV RESP DIS, V88, P167
[34]   PATTERNS OF INFECTIONS WITH ADENOVIRUS TYPES-4,-7 AND-21 IN MILITARY RECRUITS DURING A 9-YEAR SURVEY [J].
VANDERVEEN, J ;
OEI, KG ;
ABARBANEL, MF .
JOURNAL OF HYGIENE-CAMBRIDGE, 1969, 67 (02) :255-+
[35]  
VANDERVEEN J, 1957, AM J HYG, V65, P119
[36]  
VANDERVEEN J, 1960, J IMMUNOL, V84, P562
[37]   Co-infections of adenovirus species in previously vaccinated patients [J].
Vora, Gary J. ;
Lin, Baochuan ;
Gratwick, Kevin ;
Meador, Carolyn ;
Hansen, Christian ;
Tibbetts, Clark ;
Stenger, David A. ;
Irvine, Marina ;
Seto, Donald ;
Purkayastha, Anjan ;
Freed, Nikki E. ;
Gibson, Marylou G. ;
Russell, Kevin ;
Metzgar, David .
EMERGING INFECTIOUS DISEASES, 2006, 12 (06) :921-930
[38]  
WADELL G, 1984, CURR TOP MICROBIOL, V110, P191
[39]  
Wadell G, 1994, ENCY VIROLOGY, V1, P1
[40]   Type-specific identification of human adenovirus 3, 7, and 21 by a multiplex PCR assay [J].
Xu, WH ;
Erdman, DD .
JOURNAL OF MEDICAL VIROLOGY, 2001, 64 (04) :537-542